心血管超音波システムの世界市場：洞察、競合情勢、市場予測：2030年

世界の心血管超音波システムの市場規模は、2023年に16億1,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に4.79％のCAGRで拡大し、2030年には21億1,000万米ドルに達すると予測されています。心血管超音波システム市場は、高齢者人口の増加、心血管疾患の発生率の上昇、座りがちなライフスタイルの増加、心血管超音波システムに対する規制認可の上昇など、さまざまな要因によってプラスの成長が促進されています。

心血管超音波システム市場の主な促進要因の1つは、心血管疾患を患う高齢者人口の増加であり、2022年10月に発表された世界保健機関（WHO）のデータによると、2015～2050年の間に60歳以上の高齢者数は12～22％から倍増し、2050年には21億人に達すると推定されています。さらに2030年には、世界の6人に1人が60歳以上になるといいます。上記の出典によれば、80歳以上の高齢者の数は2020年から2050年の間に3倍になり、4億2,600万人に達すると予想されています。年齢が上がるにつれて、心臓発作、先天性心疾患、冠動脈疾患、大動脈疾患などの心血管系疾患を患う機会も増えます。したがって、高齢者人口の増加は、心血管超音波システムの需要を増加させ、これは予測期間中に心血管超音波システム全体の市場成長を急増させるとみられています。

当レポートでは、世界の心血管超音波システム市場について調査し、市場の概要とともに、製品タイプ別、技術別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 心血管超音波システム市場レポートのイントロダクション

第2章 心血管超音波システム市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 心血管超音波システム市場の主な要因分析

• 心血管超音波システム市場の促進要因
• 心血管超音波システム市場の抑制要因と課題
• 心血管超音波システム市場の機会

第5章 心血管超音波システム市場におけるポーターのファイブフォース分析

第6章 心血管超音波システム市場に対するCOVID-19の影響分析

第7章 心血管超音波システム市場の概要

• 製品タイプ別
• 技術別
• エンドユーザー別
• 地域別

第8章 心血管超音波システム市場の世界企業シェア分析-主要3～5社

第9章 心血管超音波システム市場の企業と製品プロファイル

• Koninklijke Philips N.V
• Hitachi Ltd
• Siemens Healthcare GmbH
• CANON MEDICAL SYSTEMS CORPORATION
• General Electric Company
• ESAOTE SPA
• SAMSUNGHEALTHCARE
• Shenzhen Mindray Bio-Medical Electronics Co Ltd
• Vave Health Inc
• FUJIFILM Healthcare Europe
• Whale Imaging
• Trivitron Healthcare
• ATYS MEDICAL
• Boston Scientific Corporation
• CHISON Medical Technologies Co. Ltd
• Narang Medical Limited
• Clarius
• Dawei Medical
• FUJIFILM Sonosite Inc

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Cardiovascular Ultrasound System Market in Global (2021-2030)
• Table 4: Cardiovascular Ultrasound System Market in Global by Product Type (2021-2030)
• Table 5: Cardiovascular Ultrasound System Market in Global by Technology Type (2021-2030)
• Table 6: Cardiovascular Ultrasound System Market in Global by Display Type (2021-2030)
• Table 7: Cardiovascular Ultrasound System Market in Global by End-User (2021-2030)
• Table 8: Cardiovascular Ultrasound System Market in Global by Geography (2021-2030)
• Table 9: Cardiovascular Ultrasound System Market in North America (2021-2030)
• Table 10: Cardiovascular Ultrasound System Market in North America by Country (2021-2030)
• Table 11: Cardiovascular Ultrasound System Market in the US (2021-2030)
• Table 12: Cardiovascular Ultrasound System Market in Canada (2021-2030)
• Table 13: Cardiovascular Ultrasound System Market in Mexico (2021-2030)
• Table 14: Cardiovascular Ultrasound System Market in Europe (2021-2030)
• Table 15: Cardiovascular Ultrasound System Market in Europe by Country (2021-2030)
• Table 16: Cardiovascular Ultrasound System Market in France (2021-2030)
• Table 17: Cardiovascular Ultrasound System Market in Germany (2021-2030)
• Table 18: Cardiovascular Ultrasound System Market in the United Kingdom (2021-2030)
• Table 19: Cardiovascular Ultrasound System Market in Italy (2021-2030)
• Table 20: Cardiovascular Ultrasound System Market in Spain (2021-2030)
• Table 21: Cardiovascular Ultrasound System Market in Russia (2021-2030)
• Table 22: Cardiovascular Ultrasound System Market in Rest of Europe (2021-2030)
• Table 23: Cardiovascular Ultrasound System Market in APAC (2021-2030)
• Table 24: Cardiovascular Ultrasound System Market in APAC by Country (2021-2030)
• Table 25: Cardiovascular Ultrasound System Market in China (2021-2030)
• Table 26: Cardiovascular Ultrasound System Market in Japan (2021-2030)
• Table 27: Cardiovascular Ultrasound System Market in India (2021-2030)
• Table 28: Cardiovascular Ultrasound System Market in Australia (2021-2030)
• Table 29: Cardiovascular Ultrasound System Market in South Korea (2021-2030)
• Table 30: Cardiovascular Ultrasound System Market in Rest of APAC (2021-2030)
• Table 31: Cardiovascular Ultrasound System Market in Rest of World (2021-2030)
• Table 32: Cardiovascular Ultrasound System Market in RoW by Region (2021-2030)
• Table 33: Cardiovascular Ultrasound System Market in Middle East (2021-2030)
• Table 34: Cardiovascular Ultrasound System Market in Africa (2021-2030)
• Table 35: Cardiovascular Ultrasound System Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Cardiovascular Ultrasound System Market in Global (2021-2030)
• Figure 4: Cardiovascular Ultrasound System Market in Global by Product Type (2021-2030)
• Figure 5: Cardiovascular Ultrasound System Market in Global by Technology Type (2021-2030)
• Figure 6: Cardiovascular Ultrasound System Market in Global by Display Type (2021-2030)
• Figure 7: Cardiovascular Ultrasound System Market in Global by End-User (2021-2030)
• Figure 8: Cardiovascular Ultrasound System Market in Global by Geography (2021-2030)
• Figure 9: Cardiovascular Ultrasound System Market in North America (2021-2030)
• Figure 10: Cardiovascular Ultrasound System Market in North America by Country (2021-2030)
• Figure 11: Cardiovascular Ultrasound System Market in the US (2021-2030)
• Figure 12: Cardiovascular Ultrasound System Market in Canada (2021-2030)
• Figure 13: Cardiovascular Ultrasound System Market in Mexico (2021-2030)
• Figure 14: Cardiovascular Ultrasound System Market in Europe (2021-2030)
• Figure 15: Cardiovascular Ultrasound System Market in Europe by Country (2021-2030)
• Figure 16: Cardiovascular Ultrasound System Market in France (2021-2030)
• Figure 17: Cardiovascular Ultrasound System Market in Germany (2021-2030)
• Figure 18: Cardiovascular Ultrasound System Market in the United Kingdom (2021-2030)
• Figure 19: Cardiovascular Ultrasound System Market in Italy (2021-2030)
• Figure 20: Cardiovascular Ultrasound System Market in Spain (2021-2030)
• Figure 21: Cardiovascular Ultrasound System Market in Russia (2021-2030)
• Figure 22: Cardiovascular Ultrasound System Market in Rest of Europe (2021-2030)
• Figure 23: Cardiovascular Ultrasound System Market in APAC (2021-2030)
• Figure 24: Cardiovascular Ultrasound System Market in APAC by Country (2021-2030)
• Figure 25: Cardiovascular Ultrasound System Market in China (2021-2030)
• Figure 26: Cardiovascular Ultrasound System Market in Japan (2021-2030)
• Figure 27: Cardiovascular Ultrasound System Market in India (2021-2030)
• Figure 28: Cardiovascular Ultrasound System Market in Australia (2021-2030)
• Figure 29: Cardiovascular Ultrasound System Market in South Korea (2021-2030)
• Figure 30: Cardiovascular Ultrasound System Market in Rest of APAC (2021-2030)
• Figure 31: Cardiovascular Ultrasound System Market in Rest of World (2021-2030)
• Figure 32: Cardiovascular Ultrasound System Market in RoW by Region (2021-2030)
• Figure 33: Cardiovascular Ultrasound System Market in Middle East (2021-2030)
• Figure 34: Cardiovascular Ultrasound System Market in Africa (2021-2030)
• Figure 35: Cardiovascular Ultrasound System Market in South America (2021-2030)
• Figure 36: Market Drivers
• Figure 37: Market Barriers
• Figure 38: Market Opportunities
• Figure 39: PORTER'S Five Force Analysis

Cardiovascular Ultrasound System Market By Product Type (Cart/Trolley Based And Compact/Handheld Ultrasound Devices), By Technology (2d-Ultrasound, 3d-Ultrasound, 4d-Ultrasound, And Doppler), By Display (Color And Black&White), By End-User (Hospital, Cardiology Centres, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rise in the geriatric population and the increasing incidence of cardiovascular diseases

The global cardiovascular ultrasound system market was valued at USD 1.61 billion in 2023, growing at a CAGR of 4.79% during the forecast period from 2024 to 2030 to reach USD 2.11 billion by 2030. The cardiovascular ultrasound system market is witnessing positive growth owing to various factors such as the rise in the geriatric population, the increasing incidence of cardiovascular diseases, the increase in sedentary lifestyles, and the rising regulatory approvals for the cardiovascular ultrasound system. Therefore, the market for cardiovascular ultrasound systems is expected to grow during the forecast period from 2024 to 2030.

Cardiovascular Ultrasound System Market Dynamics:

One of the main drivers of the cardiovascular ultrasound system market is the rise in the geriatric population suffering from cardiovascular disease, as per World Health Organization (WHO) data published in October 2022, it was estimated that between the years 2015-2050 the number of individuals aged 60 years and more will be doubled from 12-22% and will reach 2.1 billion by 2050. Additionally, by the year 2030, one out of every six individuals in the world will age 60 years or beyond. As per the above-mentioned source, the number of individuals aged 80 years or more is expected to get triple between the years 2020 and 2050 to reach 426 million population. As age increases chances of suffering from cardiovascular diseases such as heart attack, congenital heart disease, coronary artery disease, aorta disease, and others also increase. Therefore, the rising geriatric population increases the demand for cardiovascular ultrasound system, and this surge the cardiovascular ultrasound system overall market growth during the forecast period (2024-2030).

Moreover, another key factor that is responsible for the growth of the cardiovascular ultrasound system market is the increasing incidence of cardiovascular diseases. For instance, according to the British Heart Foundation in the year 2019, in North America, cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 suffered from a stroke. Moreover, as per the above-referenced source, in the year 2019, in Asia, there were 32,376,834 people diagnosed with cardiovascular diseases, from which 12,543,833 individuals were affected by coronary artery disease, and 8,111,044 population was suffered from a stroke. Thus, the cardiovascular ultrasound system is used to evaluate the structure, and function of the heart & associated vessels, and also provides images that are used to identify heart diseases. Therefore, these cardiovascular ultrasound systems can be used to diagnose cardiovascular diseases and will increase the demand for cardiovascular ultrasound systems, which could drive the cardiovascular ultrasound system's overall market growth during the forecast period (2024-2030).

However, the high cost of the cardiovascular ultrasound system and the lack of trained professionals to operate the cardiovascular ultrasound system can hamper the global cardiovascular ultrasound system market growth.

The ongoing Coronavirus (COVID-19) pandemic has significantly impacted the market for cardiovascular ultrasound systems as hospital admissions were limited due to lockdown restrictions, lack of staff and postponement of various diagnosis and treatment procedures made a huge impact on patient admissions in hospitals but COVID-19 also increased the level of stress in people which could result in high blood pressure or hypertension this can lead to heart attack or heart diseases as well as people with high blood pressure or cardiovascular diseases might be at greater risk for severe illness and death associated with COVID-19. Therefore, the COVID pandemic had significantly impacted the cardiovascular ultrasound systems market as the device used for the diagnosis of cardiovascular diseases in COVID patients. However, with masses being vaccinated, lockdown relaxation, resumption in hospital visits, and availability of staff for performing diagnosis procedures, the cardiovascular ultrasound system market has picked momentum again and is expected to further grow during the forecast period.

Cardiovascular Ultrasound System Market Segment Analysis:

Cardiovascular Ultrasound System Market by Product Type (Cart/Trolley Based and Compact/Handheld Ultrasound device), Technology (2D-Ultrasound, 3D-Ultrasound, 4D-Ultrasound, and Doppler), Display (Color and Black&White), End-User (Hospital, Cardiology Centers, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the by-product type segment of the cardiovascular ultrasound system market, the handheld ultrasound devices sub-segment is expected to have a significant revenue share in the year 2023. The key benefits associated with it are, that the use of handheld ultrasound systems has greatly reduced the time it takes to examine patients at the bedside compared to the traditional approach. They are compact, easy to carry & convenient, and can be kept in a bag, briefcase & other compact places, further software upgrades offering artificial intelligence & other upgrades increases the functionality of these devices, which are less complex and have cloud-based storage potential.

Therefore, the benefits associated with handheld cardiovascular ultrasound devices can increase the demand for cardiovascular ultrasound systems, which could drive the growth of the overall cardiovascular ultrasound system market during the forecast period. However, technological advancements in handheld ultrasound devices will also boost the global market growth for cardiovascular ultrasound systems.

Moreover, in November 2020, Clarius, a pioneer in miniaturizing ultrasound, announced that its Clarius PA HD hand-held, wireless ultrasound scanner is available for high-resolution cardiac imaging with the release of the Clarius Ultrasound App 7.3 for iOS and Android smart devices. Clarius PA HD ultrasound accelerates disinfection and allows clinicians to swiftly screen and monitor COVID-19 (SARS-CoV-2) patients because of its small size and lack of cables to clean.

Therefore, the interplay of the factors mentioned above will boost the cardiovascular ultrasound system demand in the market, which could drive the growth of the overall global cardiovascular ultrasound system market during the forecast period.

North America is expected to dominate the overall Cardiovascular Ultrasound System Market:

Among all the regions, North America is expected to dominate the global cardiovascular ultrasound system market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increase in sedentary lifestyles and the rising regulatory approvals for cardiovascular ultrasound systems are expected to increase the demand for cardiovascular ultrasound systems in the North America market.

As per the latest data published by the Centers for Disease Control and Prevention (CDC), in January 2020, 17.3% of people in Colorado were found to be physically inactive and 47.7% population was physically inactive in Puerto Rico of United States. Moreover, as per the latest statistics available from various research sources, in the year 2020, more than 15% of adults were physically inactive in America. Therefore, due to lack of physical activity, the risk of developing various diseases such as cardiovascular diseases which include heart attack, congenital heart disease, coronary artery disease, aorta disease, and others also increases over time. For the diagnosis of such cardiovascular diseases, ultrasound systems could be used which would help to maintain heart health. Thus, an increase in a sedentary lifestyle can increase the risk of developing cardiac-related diseases which could drive the demand for cardiovascular ultrasound systems, thereby, propelling the growth of the cardiovascular ultrasound system market.

Additionally, the rising regulatory approvals for cardiovascular ultrasound systems coupled with the rising prevalence of cardiac disease in the North America region can uplift the demand for cardiovascular ultrasound systems, which can boost the overall North America ultrasound cardiovascular system market. For instance, in October 2020, GE Healthcare, a manufacturer and distributor of diagnostic imaging devices and radiopharmaceuticals for imaging modalities used in medical imaging procedures, announced U.S. FDA 510k clearance for its ultra-edition Vivid cardiovascular ultrasound system in the United States, which contain new capabilities based on artificial intelligence (AI) that enable doctors to get quicker, more reproducible tests regularly.

Furthermore, in February 2022, Philips, a global leader in health technology, announced the FDA clearance for the United States and the launch of its point-of-care hand-held ultrasound for cardiovascular and other applications. The hand-held ultrasound system (Lumify) now has Pulse Wave Doppler which can quantify blood flow in cardiology and other applications.

Hence, due to the interplay of all the factors mentioned above, ultrasound cardiovascular system demand will increase, and this would provide a conducive growth environment for the North American region in the cardiovascular ultrasound system market.

Cardiovascular Ultrasound System Market Key Players:

Some of the key market players operating in the cardiovascular ultrasound system market include Koninklijke Philips N.V., Hitachi Ltd, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, General Electric Company, ESAOTE SPA, SAMSUNGHEALTHCARE, Shenzhen Mindray Bio-Medical Electronics Co Ltd, FUJIFILM Healthcare Europe, Whale Imaging, Trivitron Healthcare, ATYS MEDICAL, Boston Scientific Corporation, CHISON Medical Technologies Co. Ltd, Narang Medical Limited, Clarius, Dawei Medical, FUJIFILM Sonosite Inc, Vave Health Inc, and among others.

Recent Developmental Activities in the Cardiovascular Ultrasound System:

In September 2022, Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, introduced V8, a brand new, high-end ultrasound system that offers improved image quality, usability, and convenience for all medical professionals. The advanced functions from premium ultrasound systems dedicated to specific departments such as obstetrics, radiology, orthopedics, and cardiology have been implemented.

In May 2020, Royal Philips, a global leader in health technology, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market a broad variety of its ultrasound solutions for the treatment of COVID-19-related lung and cardiac complications.

In June 2019, Esaote, a leader in the biomedical equipment sector, launched MyLab(TM)X7 compact console system, a new cardiovascular ultrasound line in Portland, it is a high-end portable system that offers advanced cutting-edge clinical tools, optimized image quality, a remarkably simple workflow, and improved ergonomics for better, quicker, and more reliable decisions.

Key Takeaways from the Cardiovascular Ultrasound System Market Report Study

• Market size analysis for the current cardiovascular ultrasound system market (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the cardiovascular ultrasound system market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global cardiovascular ultrasound system
• Various opportunities are available for the other competitor in the cardiovascular ultrasound system market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current cardiovascular ultrasound system market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for cardiovascular ultrasound system market growth in the coming future?

Target Audience who can be benefited from this Cardiovascular Ultrasound System Market Report Study

• Cardiovascular ultrasound system providers
• Research organizations and consulting companies
• Cardiovascular ultrasound system-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in the cardiovascular ultrasound system
• Various end-users who want to know more about the cardiovascular ultrasound system market and the latest technological developments in the cardiovascular ultrasound system

Frequently Asked Questions for Cardiovascular Ultrasound System:

1. What is Cardiovascular Ultrasound System?

Cardiovascular ultrasounds, or echocardiograms, use ultrasound imaging to provide a picture of the heart. It is non-invasive and helps to diagnose and manage life-threatening cardiovascular diseases such as heart attack, congenital heart disease, coronary artery disease, and other diseases.

2. What is the market for Global Cardiovascular Ultrasound System?

The global cardiovascular ultrasound system market was valued at USD 1.61 billion in 2023, growing at a CAGR of 4.79% during the forecast period from 2024 to 2030 to reach USD 2.11 billion by 2030.

3. What are the drivers for the Global Cardiovascular Ultrasound System Market?

The cardiovascular ultrasound system market is witnessing positive market growth owing to the factors such as the rise in the geriatric population, the increasing incidence of cardiovascular diseases, the increase in sedentary lifestyles, and the rising regulatory approvals for cardiovascular ultrasound system

4. Who are the key players operating in the Cardiovascular Ultrasound System Market?

Some of the key market players operating in the cardiovascular ultrasound system market include Koninklijke Philips N.V., Hitachi Ltd, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, General Electric Company, ESAOTE SPA, SAMSUNGHEALTHCARE, Shenzhen Mindray Bio-Medical Electronics Co Ltd, FUJIFILM Healthcare Europe, Whale Imaging, Trivitron Healthcare, ATYS MEDICAL, Boston Scientific Corporation, CHISON Medical Technologies Co. Ltd, Narang Medical Limited, Clarius, Dawei Medical, FUJIFILM Sonosite Inc, Vave Health Inc, and among others.

5. Which region has the highest share in Cardiovascular Ultrasound System Market?

North America is expected to dominate the global cardiovascular ultrasound system market. Factors contributing to the growth are the increase in sedentary lifestyle and the rising regulatory approvals for cardiovascular ultrasound system, which contributes to the growth of the cardiovascular ultrasound system market in the North America region.

Table of Contents

1.Cardiovascular Ultrasound System Market Report Introduction

2.Cardiovascular Ultrasound System Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The US
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Cardiovascular Ultrasound System Market Key Factors Analysis

• 4.1. Cardiovascular Ultrasound System Market Drivers
  • 4.1.1. A rise in the Geriatric Population
  • 4.1.2. Increasing Incidence of Cardiovascular Diseases
  • 4.1.3. Increase in Sedentary Lifestyle
  • 4.1.4. Rising Regulatory Approvals for Cardiovascular Ultrasound System
• 4.2. Cardiovascular Ultrasound System Market Restraints And Challenges
  • 4.2.1. High Cost of Cardiovascular Ultrasound System
  • 4.2.2. Lack of Trained Professionals to Operate Cardiovascular Ultrasound Systems
• 4.3. Cardiovascular Ultrasound System Market Opportunities
  • 4.3.1. Increasing Research and Development Activities in Cardiovascular Ultrasound System
  • 4.3.2. Increasing Artificial Intelligence Guided Ultrasound Systems

5. Cardiovascular Ultrasound System Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Cardiovascular Ultrasound System Market

7. Cardiovascular Ultrasound System Market Layout

• 7.1. By Product Type
  • 7.1.1. Cart/Trolley Based
  • 7.1.2. Compact/Handheld Ultrasound Devices
• 7.2. By Technology
  • 7.2.1. 2D-Ultrasound
  • 7.2.2. 3D-Ultrasound
  • 7.2.3. 4D-Ultrasound
  • 7.2.4. Doppler
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Cardiology Centers
  • 7.3.3. Ambulatory Surgical Centers
  • 7.3.4. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.2.6. Russia Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.2.7. Rest of Europe Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.3.3. India Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Cardiovascular Ultrasound Sytem Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Cardiovascular Ultrasound System Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Cardiovascular Ultrasound System Market Size in USD million (2021-2030)

8. Cardiovascular Ultrasound System market Global Company Share Analysis - Key 3-5 Companies

9. Cardiovascular Ultrasound System Market Company and Product Profiles

• 9.1. Koninklijke Philips N.V
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Hitachi Ltd
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Siemens Healthcare GmbH
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. CANON MEDICAL SYSTEMS CORPORATION
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. General Electric Company
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. ESAOTE SPA
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. SAMSUNGHEALTHCARE
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Vave Health Inc
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. FUJIFILM Healthcare Europe
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Whale Imaging
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Trivitron Healthcare
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. ATYS MEDICAL
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Boston Scientific Corporation
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. CHISON Medical Technologies Co. Ltd
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Narang Medical Limited
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Clarius
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Dawei Medical
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. FUJIFILM Sonosite Inc
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us